| Year |
Citation |
Score |
| 2022 |
Murdoch B, Jandura A, Caulfield T. Reconsenting paediatric research participants for use of identifying data. Journal of Medical Ethics. PMID 35046134 DOI: 10.1136/medethics-2021-107958 |
0.33 |
|
| 2020 |
Murdoch B, Caulfield T. Non-Invasive Prenatal Screening: Navigating the Relevant Legal Norms. Journal of Obstetrics and Gynaecology Canada : Jogc = Journal D'Obstetrique Et Gynecologie Du Canada : Jogc. PMID 32694073 DOI: 10.1016/J.Jogc.2020.03.020 |
0.342 |
|
| 2020 |
Caulfield T, Murdoch B, Sapir-Pichhadze R, Keown P. Policy Challenges for Organ Allocation in an Era of "Precision Medicine". Canadian Journal of Kidney Health and Disease. 7: 2054358120912655. PMID 32231786 DOI: 10.1177/2054358120912655 |
0.327 |
|
| 2020 |
Marcon AR, Allan D, Barber M, Murdoch B, Caulfield T. Portrayal of umbilical cord blood research in the North American popular press: promise or hype? Regenerative Medicine. PMID 32101099 DOI: 10.2217/Rme-2019-0149 |
0.361 |
|
| 2020 |
Caulfield T, Murdoch B, Ogbogu U. Research, Digital Health Information and Promises of Privacy: Revisiting the Issue of Consent Canadian Journal of Bioethics. 3: 164. DOI: 10.7202/1070237Ar |
0.448 |
|
| 2019 |
Marcon AR, Caulfield T, Toews M. Public Solicitation and The Canadian Media: Two Cases of Living Liver Donation, Two Different Stories. Transplantation Direct. 5: e508. PMID 32095503 DOI: 10.1097/Txd.0000000000000950 |
0.302 |
|
| 2019 |
Caulfield T, Murdoch B. Regulatory and policy tools to address unproven stem cell interventions in Canada: the need for action. Bmc Medical Ethics. 20: 51. PMID 31383026 DOI: 10.1186/S12910-019-0388-4 |
0.34 |
|
| 2019 |
Hawke B, Przybylo AR, Paciulli D, Caulfield T, Zarzeczny A, Master Z. How to Peddle Hope: An Analysis of YouTube Patient Testimonials of Unproven Stem Cell Treatments. Stem Cell Reports. 12: 1186-1189. PMID 31189092 DOI: 10.1016/J.Stemcr.2019.05.009 |
0.308 |
|
| 2019 |
Murdoch B, Marcon AR, Downie D, Caulfield T. Media portrayal of illness-related medical crowdfunding: A content analysis of newspaper articles in the United States and Canada. Plos One. 14: e0215805. PMID 31013310 DOI: 10.1371/Journal.Pone.0215805 |
0.301 |
|
| 2019 |
Park JY, Risher MT, Caulfield T, Baudhuin LM, Schwab AP. Privacy in Direct-to-Consumer Genetic Testing. Clinical Chemistry. PMID 30819664 DOI: 10.1373/Clinchem.2018.298935 |
0.32 |
|
| 2019 |
Caulfield T, Marcon AR, Murdoch B, Brown JM, Perrault ST, Jarry J, Snyder J, Anthony SJ, Brooks S, Master Z, Rachul C, Ogbogu U, Greenberg J, Zarzeczny A, Hyde-Lay R. Health Misinformation and the Power of Narrative Messaging in the Public Sphere Canadian Journal of Bioethics. 2: 52-60. DOI: 10.7202/1060911Ar |
0.351 |
|
| 2018 |
Zarzeczny A, Atkins H, Illes J, Kimmelman J, Master Z, Robillard JM, Snyder J, Turner L, Zettler PJ, Caulfield T. The stem cell market and policy options: a call for clarity. Journal of Law and the Biosciences. 5: 743-758. PMID 31143461 DOI: 10.1093/Jlb/Lsy025 |
0.408 |
|
| 2018 |
Caulfield T. Spinning the Genome: Why Science Hype Matters. Perspectives in Biology and Medicine. 61: 560-571. PMID 30613038 DOI: 10.1353/Pbm.2018.0065 |
0.376 |
|
| 2018 |
Borry P, Caulfield T, Estivill X, Loland S, McNamee M, Knoppers BM. Geolocalisation of athletes for out-of-competition drug testing: ethical considerations. Position statement by the WADA Ethics Panel. British Journal of Sports Medicine. PMID 29500253 DOI: 10.1136/Bjsports-2017-098299 |
0.354 |
|
| 2018 |
Murdoch B, Zarzeczny A, Caulfield T. Exploiting science? A systematic analysis of complementary and alternative medicine clinic websites' marketing of stem cell therapies. Bmj Open. 8: e019414. PMID 29490963 DOI: 10.1136/Bmjopen-2017-019414 |
0.362 |
|
| 2018 |
Marcon AR, Bieber M, Caulfield T. Representing a "revolution": how the popular press has portrayed personalized medicine. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 29300377 DOI: 10.1038/Gim.2017.217 |
0.351 |
|
| 2018 |
Murdoch B, Caulfield T. Doing Research with Vulnerable Populations: The Case of Intravenous Drug Users BioéThiqueonline. 5: 32. DOI: 10.7202/1044290Ar |
0.429 |
|
| 2017 |
Marcon AR, Murdoch B, Caulfield T. Fake news portrayals of stem cells and stem cell research. Regenerative Medicine. 12: 765-775. PMID 29115183 DOI: 10.2217/Rme-2017-0060 |
0.367 |
|
| 2017 |
Caulfield T, Murdoch B. Genes, cells, and biobanks: Yes, there's still a consent problem. Plos Biology. 15: e2002654. PMID 28742850 DOI: 10.1371/Journal.Pbio.2002654 |
0.415 |
|
| 2017 |
Sipp D, Caulfield T, Kaye J, Barfoot J, Blackburn C, Chan S, De Luca M, Kent A, McCabe C, Munsie M, Sleeboom-Faulkner M, Sugarman J, van Zimmeren E, Zarzeczny A, Rasko JEJ. Marketing of unproven stem cell-based interventions: A call to action. Science Translational Medicine. 9. PMID 28679655 DOI: 10.1126/Scitranslmed.Aag0426 |
0.319 |
|
| 2017 |
Murdoch B, Ravitsky V, Ogbogu U, Ali-Khan S, Bertier G, Birko S, Bubela T, De Beer J, Dupras C, Ellis M, Granados Moreno P, Joly Y, Kamenova K, Master Z, Marcon A, ... ... Caulfield T, et al. Non-invasive Prenatal Testing and the Unveiling of an Impaired Translation Process. Journal of Obstetrics and Gynaecology Canada : Jogc = Journal D'Obstetrique Et Gynecologie Du Canada : Jogc. 39: 10-17. PMID 28062017 DOI: 10.1016/J.Jogc.2016.09.004 |
0.356 |
|
| 2017 |
Murdoch B, Caulfield T. The challenge of human challenge research models: A Canadian perspective: Medical Law International. 17: 273-284. DOI: 10.1177/0968533217736561 |
0.355 |
|
| 2016 |
Du L, Murdoch B, Chiu C, Caulfield T. Compelled Disclosure of Confidential Information in Patient Safety Research. Journal of Patient Safety. PMID 27811589 DOI: 10.1097/Pts.0000000000000293 |
0.428 |
|
| 2016 |
Caulfield T, Duijst W, Bos M, Chassis I, Codreanu I, Danovitch G, Gill J, Ivanovski N, Shin M. Trafficking in Human Beings for the Purpose of Organ Removal and the Ethical and Legal Obligations of Healthcare Providers. Transplantation Direct. 2: e60. PMID 27500253 DOI: 10.1097/Txd.0000000000000566 |
0.354 |
|
| 2016 |
Kimmelman J, Hyun I, Benvenisty N, Caulfield T, Heslop HE, Murry CE, Sipp D, Studer L, Sugarman J, Daley GQ. Policy: Global standards for stem-cell research. Nature. 533: 311-3. PMID 27193661 DOI: 10.1038/533311A |
0.419 |
|
| 2016 |
Daley GQ, Hyun I, Apperley JF, Barker RA, Benvenisty N, Bredenoord AL, Breuer CK, Caulfield T, Cedars MI, Frey-Vasconcells J, Heslop HE, Jin Y, Lee RT, McCabe C, Munsie M, et al. Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines. Stem Cell Reports. PMID 27185282 DOI: 10.1016/J.Stemcr.2016.05.001 |
0.434 |
|
| 2016 |
Kimmelman J, Heslop HE, Sugarman J, Studer L, Benvenisty N, Caulfield T, Hyun I, Murry CE, Sipp D, Daley GQ. New ISSCR guidelines: clinical translation of stem cell research. Lancet (London, England). PMID 27179752 DOI: 10.1016/S0140-6736(16)30390-7 |
0.377 |
|
| 2016 |
Caulfield T, Sipp D, Murry CE, Daley GQ, Kimmelman J. SCIENTIFIC COMMUNITY. Confronting stem cell hype. Science (New York, N.Y.). 352: 776-7. PMID 27174977 DOI: 10.1126/Science.Aaf4620 |
0.47 |
|
| 2016 |
Auffray C, Caulfield T, Griffin JL, Khoury MJ, Lupski JR, Schwab M. From genomic medicine to precision medicine: highlights of 2015. Genome Medicine. 8: 12. PMID 26825779 DOI: 10.1186/S13073-016-0265-4 |
0.324 |
|
| 2015 |
Caulfield T, Borry P, Toews M, Elger BS, Greely HT, McGuire A. Marginally scientific? Genetic testing of children and adolescents for lifestyle and health promotion. Journal of Law and the Biosciences. 2: 627-644. PMID 27774215 DOI: 10.1093/Jlb/Lsv038 |
0.329 |
|
| 2015 |
Caulfield T. Obesity Genes, Personalized Medicine, and Public Health Policy. Current Obesity Reports. 4: 319-23. PMID 26627489 DOI: 10.1007/S13679-015-0163-X |
0.363 |
|
| 2015 |
Caulfield T, Ogbogu U. The commercialization of university-based research: Balancing risks and benefits. Bmc Medical Ethics. 16: 70. PMID 26464028 DOI: 10.1186/S12910-015-0064-2 |
0.391 |
|
| 2015 |
Rachul C, Caulfield T. The media and access issues: content analysis of Canadian newspaper coverage of health policy decisions. Orphanet Journal of Rare Diseases. 10: 102. PMID 26303029 DOI: 10.1186/S13023-015-0320-Z |
0.355 |
|
| 2015 |
Du L, Kamenova K, Caulfield T. The gene patent controversy on Twitter: a case study of Twitter users' responses to the CHEO lawsuit against Long QT gene patents. Bmc Medical Ethics. 16: 55. PMID 26302779 DOI: 10.1186/S12910-015-0049-1 |
0.32 |
|
| 2015 |
Rachul C, Caulfield T. Gordie Howe's Stem Cell 'Miracle': A Qualitative Analysis of News Coverage and Readers' Comments in Newspapers and Sports Websites. Stem Cell Reviews. 11: 667-75. PMID 26163831 DOI: 10.1007/S12015-015-9606-8 |
0.382 |
|
| 2015 |
Kamenova K, Caulfield T. Stem cell hype: media portrayal of therapy translation. Science Translational Medicine. 7: 278ps4. PMID 25761887 DOI: 10.1126/Scitranslmed.3010496 |
0.414 |
|
| 2015 |
Caulfield T, Kamenova K, Ogbogu U, Zarzeczny A, Baltz J, Benjaminy S, Cassar PA, Clark M, Isasi R, Knoppers B, Knowles L, Korbutt G, Lavery JV, Lomax GP, Master Z, et al. Research ethics and stem cells: Is it time to re-think current approaches to oversight? Embo Reports. 16: 2-6. PMID 25476708 DOI: 10.15252/Embr.201439819 |
0.611 |
|
| 2015 |
Master Z, Campo-Engelstein L, Caulfield T. Scientists' perspectives on consent in the context of biobanking research. European Journal of Human Genetics : Ejhg. 23: 569-74. PMID 25074466 DOI: 10.1038/Ejhg.2014.143 |
0.371 |
|
| 2015 |
Shelley J, Clark M, Caulfield T. The face of chiropractic: evidence-based? Focus On Alternative and Complementary Therapies. 20: 13-22. DOI: 10.1111/Fct.12151 |
0.33 |
|
| 2014 |
Caulfield T, Burningham S, Joly Y, Master Z, Shabani M, Borry P, Becker A, Burgess M, Calder K, Critchley C, Edwards K, Fullerton SM, Gottweis H, Hyde-Lay R, Illes J, et al. A review of the key issues associated with the commercialization of biobanks. Journal of Law and the Biosciences. 1: 94-110. PMID 27774156 DOI: 10.1093/Jlb/Lst004 |
0.509 |
|
| 2014 |
Zarzeczny A, Caulfield T, Ogbogu U, Bell P, Crooks VA, Kamenova K, Master Z, Rachul C, Snyder J, Toews M, Zoeller S. Professional regulation: a potentially valuable tool in responding to "stem cell tourism". Stem Cell Reports. 3: 379-84. PMID 25241736 DOI: 10.1016/J.Stemcr.2014.06.016 |
0.371 |
|
| 2014 |
Master Z, Robertson K, Frederick D, Rachul C, Caulfield T. Stem cell tourism and public education: the missing elements. Cell Stem Cell. 15: 267-70. PMID 25192461 DOI: 10.1016/J.Stem.2014.08.009 |
0.346 |
|
| 2014 |
Ogbogu U, Toews M, Ollenberger A, Borry P, Nobile H, Bergmann M, Caulfield T. Newspaper coverage of biobanks. Peerj. 2: e500. PMID 25101229 DOI: 10.7717/Peerj.500 |
0.445 |
|
| 2014 |
Caulfield T, Zarzeczny A. Defining ‘medical necessity’ in an age of personalised medicine: A view from Canada Bioessays. 36: 813-817. PMID 25059840 DOI: 10.1002/Bies.201400073 |
0.336 |
|
| 2014 |
Kamenova K, Reshef A, Caulfield T. Representations of Stem Cell Clinics on Twitter Stem Cell Reviews and Reports. 10: 753-760. PMID 24970380 DOI: 10.1007/S12015-014-9534-Z |
0.365 |
|
| 2014 |
Caulfield T, Borry P, Gottweis H. Industry involvement in publicly funded biobanks Nature Reviews Genetics. 15: 220-220. PMID 24772494 DOI: 10.1038/Nrg3704 |
0.309 |
|
| 2014 |
Takezawa Y, Kato K, Oota H, Caulfield T, Fujimoto A, Honda S, Kamatani N, Kawamura S, Kawashima K, Kimura R, Matsumae H, Saito A, Savage PE, Seguchi N, Shimizu K, et al. Human genetic research, race, ethnicity and the labeling of populations: recommendations based on an interdisciplinary workshop in Japan. Bmc Medical Ethics. 15: 33. PMID 24758583 DOI: 10.1186/1472-6939-15-33 |
0.395 |
|
| 2014 |
Ogbogu U, Burningham S, Ollenberger A, Calder K, Du L, El Emam K, Hyde-Lay R, Isasi R, Joly Y, Kerr I, Malin B, McDonald M, Penney S, Piat G, Roy DC, ... ... Caulfield T, et al. Policy recommendations for addressing privacy challenges associated with cell-based research and interventions. Bmc Medical Ethics. 15: 7. PMID 24485220 DOI: 10.1186/1472-6939-15-7 |
0.598 |
|
| 2014 |
Koper M, Bubela T, Caulfield T, Boon H. Media Portrayal of Conflicts of Interest in Biomedical Research Health Law Review. 15: 30. DOI: 10.7939/R3R00P |
0.393 |
|
| 2014 |
Fernando K, Bubela T, Caulfield T. Public Trust and Regulatory Governance as represented through the Media Health Law Review. 15: 12. DOI: 10.7939/R3G58Z |
0.361 |
|
| 2014 |
Caulfield T, Bubela T. Media Representations of Genetic Discoveries: Hype in the Headlines? Health Law Review. 12: 53. DOI: 10.7939/R30G46 |
0.389 |
|
| 2014 |
Vohra S, Kawchuk GN, Boon H, Caulfield T, Pohlman KA, O'Beirne M. SafetyNET: An interdisciplinary research program to support a safety culture for spinal manipulation therapy European Journal of Integrative Medicine. 6: 473-477. DOI: 10.1016/J.Eujim.2014.06.005 |
0.353 |
|
| 2013 |
Caulfield T, Evans J, McGuire A, McCabe C, Bubela T, Cook-Deegan R, Fishman J, Hogarth S, Miller FA, Ravitsky V, Biesecker B, Borry P, Cho MK, Carroll JC, Etchegary H, et al. Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate. Plos Biology. 11: e1001699. PMID 24223516 DOI: 10.1371/Journal.Pbio.1001699 |
0.309 |
|
| 2013 |
McGuire AL, Joffe S, Koenig BA, Biesecker BB, McCullough LB, Blumenthal-Barby JS, Caulfield T, Terry SF, Green RC. Point-counterpoint. Ethics and genomic incidental findings. Science (New York, N.Y.). 340: 1047-8. PMID 23686340 DOI: 10.1126/Science.1240156 |
0.33 |
|
| 2013 |
Caulfield T, Borry P. Direct-to-consumer genetic testing - where should we focus the policy debate? The Medical Journal of Australia. 198: 499-500. PMID 23682895 DOI: 10.5694/Mja12.11024 |
0.321 |
|
| 2013 |
Ogbogu U, Rachul C, Caulfield T. Reassessing direct-to-consumer portrayals of unproven stem cell therapies: is it getting better? Regenerative Medicine. 8: 361-369. PMID 23627829 DOI: 10.2217/Rme.13.15 |
0.354 |
|
| 2013 |
Master Z, Zarzeczny A, Rachul C, Caulfield T. What's missing? Discussing stem cell translational research in educational information on stem cell "tourism". The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics. 41: 254-68. PMID 23581669 DOI: 10.1111/Jlme.12017 |
0.386 |
|
| 2013 |
Caulfield T, Chandrasekharan S, Joly Y, Cook-Deegan R. Harm, hype and evidence: ELSI research and policy guidance. Genome Medicine. 5: 21. PMID 23534337 DOI: 10.1186/Gm425 |
0.424 |
|
| 2013 |
Master Z, Claudio JO, Rachul C, Wang JC, Minden MD, Caulfield T. Cancer patient perceptions on the ethical and legal issues related to biobanking. Bmc Medical Genomics. 6: 8. PMID 23497701 DOI: 10.1186/1755-8794-6-8 |
0.395 |
|
| 2013 |
Haimes E, Skene L, Ballantyne AJ, Caulfield T, Goldstein LS, Hyun I, Kimmelman J, Robert JS, Roxland BE, Scott CT, Solbakk JH, Sugarman J, Taylor PL, Testa G. Position statement on the provision and procurement of human eggs for stem cell research. Cell Stem Cell. 12: 285-91. PMID 23472870 DOI: 10.1016/J.Stem.2013.02.002 |
0.395 |
|
| 2013 |
Auffray C, Caulfield T, Khoury MJ, Lupski JR, Schwab M, Veenstra T. 2012 highlights in translational 'omics Genome Medicine. 5: 10-10. PMID 23369291 DOI: 10.1186/Gm414 |
0.357 |
|
| 2013 |
Ogbogu U, Du L, Rachul C, Bélanger L, Caulfield T. Chinese newspaper coverage of (unproven) stem cell therapies and their providers. Stem Cell Reviews. 9: 111-8. PMID 23292462 DOI: 10.1007/S12015-012-9425-0 |
0.375 |
|
| 2012 |
Caulfield T, Rachul C, Nelson E. Biobanking, Consent, and Control: A Survey of Albertans on Key Research Ethics Issues Biopreservation and Biobanking. 10: 433-438. PMID 24845044 DOI: 10.1089/Bio.2012.0029 |
0.417 |
|
| 2012 |
Barnieh L, Klarenbach S, Gill JS, Caulfield T, Manns B. Attitudes toward strategies to increase organ donation: views of the general public and health professionals. Clinical Journal of the American Society of Nephrology. 7: 1956-1963. PMID 23024166 DOI: 10.2215/Cjn.04100412 |
0.312 |
|
| 2012 |
Bubela T, Reshef A, Li MD, Atkins H, Caulfield T, Culme-Seymour E, Gold ER, Illes J, Isasi R, McCabe C, Ogbogu U, Piret J, Mason C. Enabling advanced cell therapies (EnACT): invitation to an online forum on resolving barriers to clinical translation. Regenerative Medicine. 7: 735-40. PMID 23020169 DOI: 10.2217/Rme.12.59 |
0.347 |
|
| 2012 |
Caulfield T, McGuire A. Athletes' use of unproven stem cell therapies: adding to inappropriate media hype? Molecular Therapy. 20: 1656-1658. PMID 22945228 DOI: 10.1038/Mt.2012.172 |
0.411 |
|
| 2012 |
Master Z, Nelson E, Murdoch B, Caulfield T. Biobanks, consent and claims of consensus. Nature Methods. 9: 885-8. PMID 22936169 DOI: 10.1038/Nmeth.2142 |
0.392 |
|
| 2012 |
Caulfield T, Rachul C, Zarzeczny A. The Evolution of Policy Issues in Stem Cell Research: An International Survey Stem Cell Reviews and Reports. 8: 1037-1042. PMID 22851302 DOI: 10.1007/S12015-012-9404-5 |
0.474 |
|
| 2012 |
Caulfield T. Should we call it fraud Hastings Center Report. 42: 49. PMID 22616400 DOI: 10.1002/Hast.15 |
0.344 |
|
| 2012 |
Caulfield T, Condit C. Science and the sources of hype. Public Health Genomics. 15: 209-217. PMID 22488464 DOI: 10.1159/000336533 |
0.367 |
|
| 2012 |
Caulfield T, Harmon SH, Joly Y. Open science versus commercialization: a modern research conflict? Genome Medicine. 4: 17-17. PMID 22369790 DOI: 10.1186/Gm316 |
0.387 |
|
| 2012 |
Scott CT, Caulfield T, Borgelt E, Illes J. Personal medicine--the new banking crisis. Nature Biotechnology. 30: 141-7. PMID 22318029 DOI: 10.1038/Nbt.2116 |
0.399 |
|
| 2012 |
Zarzeczny A, Caulfield T. Legal liability and research ethics boards: The case of neuroimaging and incidental findings International Journal of Law and Psychiatry. 35: 137-145. PMID 22304986 DOI: 10.1016/J.Ijlp.2011.12.005 |
0.417 |
|
| 2012 |
Caulfield T, Ogbogu U. Stem cell research, scientific freedom and the commodification concern. Embo Reports. 13: 12-16. PMID 22134549 DOI: 10.1038/Embor.2011.232 |
0.421 |
|
| 2012 |
Caulfield T. DTC genetic testing: pendulum swings and policy paradoxes. Clinical Genetics. 81: 4-6. PMID 21999657 DOI: 10.1111/J.1399-0004.2011.01799.X |
0.359 |
|
| 2012 |
Caulfield T, McGuire AL. Direct-to-consumer genetic testing: perceptions, problems, and policy responses. Annual Review of Medicine. 63: 23-33. PMID 21888511 DOI: 10.1146/Annurev-Med-062110-123753 |
0.36 |
|
| 2012 |
Rachul C, McGuire A, Caulfield T. Public Perceptions and Biobanking: What Does the Research Really Say? Studies in Ethics, Law and Technology. 6. DOI: 10.1515/1941-6008.1177 |
0.397 |
|
| 2012 |
Harmon SHE, Caulfield T, Joly Y. Commercialization versus open science: Making sense of the message (s) in the bottle Medical Law International. 12: 3-10. DOI: 10.1177/0968533212441887 |
0.387 |
|
| 2012 |
Scott CT, Caulfield T, Borgelt E, Illes J. Personal medicine-the new banking crisis (Nature Biotechnology (2012) 30 (141-147) Nature Biotechnology. 30: 466. DOI: 10.1038/Nbt0512-466A |
0.316 |
|
| 2011 |
Caulfield T, Rachul C. Supported by science?: What Canadian naturopaths advertise to the public Allergy, Asthma & Clinical Immunology. 7: 14-14. PMID 21920039 DOI: 10.1186/1710-1492-7-14 |
0.36 |
|
| 2011 |
Stafinski T, Menon D, Marshall D, Caulfield T. Societal values in the allocation of healthcare resources: is it all about the health gain? The Patient: Patient-Centered Outcomes Research. 4: 207-225. PMID 21815706 DOI: 10.2165/11588880-000000000-00000 |
0.339 |
|
| 2011 |
Caulfield T, Rachul C. Science Spin: iPS Cell Research in the News Clinical Pharmacology & Therapeutics. 89: 644-646. PMID 21512523 DOI: 10.1038/Clpt.2010.309 |
0.347 |
|
| 2011 |
Caulfield T. Reflections on the Gene Patent War: The Myriad Battle, Sputnik and Beyond Clinical Chemistry. 57: 977-979. PMID 21507909 DOI: 10.1373/Clinchem.2011.162313 |
0.384 |
|
| 2011 |
Caulfield T. Direct-to-consumer testing: if consumers are not anxious, why are policymakers? Human Genetics. 130: 23-25. PMID 21479954 DOI: 10.1007/S00439-011-0987-8 |
0.325 |
|
| 2011 |
Auffray C, Caulfield T, Khoury MJ, Lupski JR, Schwab M, Veenstra TD. Genome Medicine: past, present and future Genome Medicine. 3: 6-6. PMID 21345269 DOI: 10.1186/Gm220 |
0.323 |
|
| 2011 |
Rachul C, Ouellette C, Caulfield T. Tracing the use and source of racial terminology in representations of genetic research Genetics in Medicine. 13: 314-319. PMID 20890209 DOI: 10.1097/Gim.0B013E3181F5Cf9A |
0.362 |
|
| 2011 |
Master Z, Ries NM, Caulfield T. Balancing Efficiency and the Protection of Research Participants: Canadian Allergy/Asthma Researchers' Perspectives on the Ethics Review of Multi-Site Health Research Journal of Clinical Research & Bioethics. 2: 1-4. DOI: 10.4172/2155-9627.1000104E |
0.393 |
|
| 2011 |
Rachul C, Caulfield T. Food Allergy Policy and the Popular Press Perspectives From Canadian Newspapers Journal of Asthma & Allergy Educators. 2: 282-287. DOI: 10.1177/2150129711410691 |
0.353 |
|
| 2011 |
Hyde-Lay R, Caulfield T. Media Representations of Allergy and Asthma Issues, Policy and Research: Views from the AllerGen Research Community The Journal of Allergy and Clinical Immunology. 127. DOI: 10.1016/J.Jaci.2010.12.189 |
0.367 |
|
| 2010 |
Joly Y, Caulfield T, Knoppers BM, Harmsen E, Pastinen T. The commercialization of genomic research in Canada. Healthcare Policy = Politiques De Sante. 6: 24-32. PMID 22043221 |
0.309 |
|
| 2010 |
Gill JS, Goldberg A, Prasad GV, Fortin MC, Hansen TB, Levin A, Gill J, Tonelli M, Tibbles LA, Knoll G, Cole EH, Caulfield T. Policy statement of Canadian Society of Transplantation and Canadian Society of Nephrology on organ trafficking and transplant tourism. Transplantation. 90: 817-20. PMID 20697329 DOI: 10.1097/Tp.0B013E3181Efd030 |
0.611 |
|
| 2010 |
Bubela TM, Caulfield T. Role and reality: technology transfer at Canadian universities Trends in Biotechnology. 28: 447-451. PMID 20598388 DOI: 10.1016/J.Tibtech.2010.06.002 |
0.349 |
|
| 2010 |
Caulfield T. Stem cell research and economic promises. Journal of Law Medicine & Ethics. 38: 303-313. PMID 20579253 DOI: 10.1111/J.1748-720X.2010.00490.X |
0.437 |
|
| 2010 |
Caulfield T, Zarzeczny A. Popular culture representations of science: views from the Canadian stem cell research community. Stem Cell Reviews and Reports. 6: 337-339. PMID 20535646 DOI: 10.1007/S12015-010-9164-Z |
0.357 |
|
| 2010 |
Zarzeczny A, Caulfield T. Stem cell tourism and doctors' duties to minors--a view from Canada. American Journal of Bioethics. 10: 3-15. PMID 20461636 DOI: 10.1080/15265161003702865 |
0.398 |
|
| 2010 |
Ries NM, LeGrandeur J, Caulfield T. Handling ethical, legal and social issues in birth cohort studies involving genetic research: responses from studies in six countries. Bmc Medical Ethics. 11: 4-4. PMID 20331891 DOI: 10.1186/1472-6939-11-4 |
0.401 |
|
| 2010 |
Caulfield T, Scott C, Hyun I, Lovell-Badge R, Kato K, Zarzeczny' A. Stem cell research policy and iPS cells Nature Methods. 7: 28-33. PMID 20038953 DOI: 10.1038/Nmeth.F.282 |
0.447 |
|
| 2010 |
Caulfield T, Ries NM, Ray PN, Shuman C, Wilson B. Direct-to-consumer genetic testing: Good, bad or benign? Clinical Genetics. 77: 101-105. PMID 19968666 DOI: 10.1111/J.1399-0004.2009.01291.X |
0.333 |
|
| 2010 |
Joly Y, Caulfield T, Knoppers BM, Harmsen E, Pastinen T. The commercialization of genomic research in Canada. Health Policy. 6: 24-32. DOI: 10.12927/Hcpol.2013.22032 |
0.421 |
|
| 2010 |
McGuire AL, Evans BJ, Caulfield T, Burke W. Response—Regulating Genetic Tests: Who Owns the Data? Science. 330: 1626-1627. DOI: 10.1126/Science.330.6011.1626-C |
0.314 |
|
| 2009 |
Zarzeczny A, Scott C, Hyun I, Bennett J, Chandler J, Chargé S, Heine H, Isasi R, Kato K, Lovell-Badge R, McNagny K, Pei D, Rossant J, Surani A, Taylor PL, ... ... Caulfield T, et al. iPS cells: mapping the policy issues. Cell. 139: 1032-7. PMID 20005794 DOI: 10.1016/J.Cell.2009.11.039 |
0.429 |
|
| 2009 |
Caulfield T. Direct-to-consumer genetics and health policy: a worst-case scenario? American Journal of Bioethics. 9: 48-50. PMID 19998115 DOI: 10.1080/15265160902918770 |
0.308 |
|
| 2009 |
Adair A, Einsiedel E, Caulfield T, Hyde-Lay R. Technology assessment and resource allocation for predictive genetic testing: A study of the perspectives of Canadian genetic health care providers Bmc Medical Ethics. 10. PMID 19538750 DOI: 10.1186/1472-6939-10-6 |
0.326 |
|
| 2009 |
Zarzeczny A, Caulfield T. Emerging ethical, legal and social issues associated with stem cell research & and the current role of the moral status of the embryo. Stem Cell Reviews and Reports. 5: 96-101. PMID 19521800 DOI: 10.1007/S12015-009-9062-4 |
0.445 |
|
| 2009 |
Caulfield T, Zarzeczny A, McCormick J, Bubela T, Critchley C, Einsiedel E, Galipeau J, Harmon S, Huynh M, Hyun I, Illes J, Isasi R, Joly Y, Laurie G, Lomax G, et al. The stem cell research environment: a patchwork of patchworks. Stem Cell Reviews. 5: 82-8. PMID 19521798 DOI: 10.1007/S12015-009-9071-3 |
0.622 |
|
| 2009 |
Bubela T, Nisbet MC, Borchelt R, Brunger F, Critchley C, Einsiedel E, Geller G, Gupta A, Hampel J, Hyde-Lay R, Jandciu EW, Jones SA, Kolopack P, Lane S, Lougheed T, ... ... Caulfield T, et al. Science communication reconsidered. Nature Biotechnology. 27: 514-8. PMID 19513051 DOI: 10.1038/Nbt0609-514 |
0.323 |
|
| 2009 |
Caulfield T, Fullerton SM, Ali-Khan SE, Arbour L, Burchard EG, Cooper RS, Hardy BJ, Harry S, Hyde-Lay R, Kahn J, Kittles R, Koenig BA, Lee SS, Malinowski M, Ravitsky V, et al. Race and ancestry in biomedical research: exploring the challenges. Genome Medicine. 1: 8. PMID 19348695 DOI: 10.1186/Gm8 |
0.447 |
|
| 2009 |
Rugg-Gunn PJ, Ogbogu U, Rossant J, Caulfield T. The challenge of regulating rapidly changing science: stem cell legislation in Canada. Cell Stem Cell. 4: 285-8. PMID 19341618 DOI: 10.1016/J.Stem.2009.03.004 |
0.432 |
|
| 2009 |
Murdoch C, Caulfield T. Commercialization, patenting and genomics: researcher perspectives Genome Medicine. 1: 22-22. PMID 19341493 DOI: 10.1186/Gm22 |
0.434 |
|
| 2009 |
Caulfield T. Nutrigenomics patents and commercialization: old wine in a new bottle? Omics a Journal of Integrative Biology. 13: 63-67. PMID 19290812 DOI: 10.1089/Omi.2008.0048 |
0.415 |
|
| 2009 |
Little J, Potter B, Allanson J, Caulfield T, Carroll JC, Wilson B. Canada: public health genomics Public Health Genomics. 12: 112-120. PMID 19039255 DOI: 10.1159/000156113 |
0.317 |
|
| 2009 |
Caulfield T, Kaye J. Broad Consent in Biobanking: Reflections on Seemingly Insurmountable Dilemmas Medical Law International. 10: 85-100. DOI: 10.1177/096853320901000201 |
0.399 |
|
| 2009 |
Caulfield T, Zarzeczny A, McCormick J, Bubela T, Chritchley C, Einsiedel E, Galipeau J, Harmon S, Huynh M, Hyun I, Illes J, Isasi R, Joly Y, Laurie G, Lomax G, et al. International stem cell environments: a world of difference Stem Cells. 1-1. DOI: 10.1038/Stemcells.2009.61 |
0.58 |
|
| 2008 |
Lau D, Ogbogu U, Taylor B, Stafinski T, Menon D, Caulfield T. Stem Cell Clinics Online: The Direct-to-Consumer Portrayal of Stem Cell Medicine Cell Stem Cell. 3: 591-594. PMID 19041775 DOI: 10.1016/J.Stem.2008.11.001 |
0.34 |
|
| 2008 |
Bubela T, Boon H, Caulfield T. Herbal remedy clinical trials in the media: a comparison with the coverage of conventional pharmaceuticals Bmc Medicine. 6: 35-35. PMID 19036123 DOI: 10.1186/1741-7015-6-35 |
0.31 |
|
| 2008 |
Caulfield T, Ogbogu U. Biomedical research and the commercialization agenda: a review of main considerations for neuroscience. Accountability in Research. 15: 303-320. PMID 18972268 DOI: 10.1080/08989620802388788 |
0.41 |
|
| 2008 |
Potter BK, Avard D, Graham ID, Entwistle VA, Caulfield TA, Chakraborty P, Kennedy C, McGuire M, Griener GG, Montgomery M, Wells GA, Wilson BJ. Guidance for considering ethical, legal, and social issues in health technology assessment: application to genetic screening. International Journal of Technology Assessment in Health Care. 24: 412-22. PMID 18828935 DOI: 10.1017/S0266462308080549 |
0.354 |
|
| 2008 |
Caulfield T, Ogbogu U, Murdoch C, Einsiedel E. Patents, commercialization and the Canadian stem cell research community. Regenerative Medicine. 3: 483-496. PMID 18588471 DOI: 10.2217/17460751.3.4.483 |
0.447 |
|
| 2008 |
Caulfield T, McGuire AL, Cho M, Buchanan JA, Burgess MM, Danilczyk U, Diaz CM, Fryer-Edwards K, Green SK, Hodosh MA, Juengst ET, Kaye J, Kedes L, Knoppers BM, Lemmens T, et al. Research ethics recommendations for whole-genome research: consensus statement. Plos Biology. 6: e73. PMID 18366258 DOI: 10.1371/Journal.Pbio.0060073 |
0.641 |
|
| 2008 |
McGuire AL, Caulfield T, Cho MK. Research ethics and the challenge of whole-genome sequencing. Nature Reviews. Genetics. 9: 152-6. PMID 18087293 DOI: 10.1038/Nrg2302 |
0.357 |
|
| 2008 |
Ogbogu U, Caulfield T, Shane G. From Human Embryos to IntErspEcIEs crEatIons: EtHIcal and lEgal uncErtaIntIEs surroundIng tHE crEatIon oF cytoplasmIc HybrIds For rEsEarcH Medical Law International. 9: 227-244. DOI: 10.1177/096853320800900302 |
0.459 |
|
| 2007 |
Caulfield T, Bubela T, Murdoch CJ. Myriad and the mass media: the covering of a gene patent controversy Genetics in Medicine. 9: 850-855. PMID 18091435 DOI: 10.1097/Gim.0B013E31815Bf965 |
0.364 |
|
| 2007 |
Nelson E, Ogbogu U, Caulfield T. An investigation of embryo donation, informed consent, and research oversight in Canadian human embryonic stem cell research. Journal of Obstetrics and Gynaecology Canada. 29: 997-1002. PMID 18053386 DOI: 10.1016/S1701-2163(16)32692-5 |
0.416 |
|
| 2007 |
Caulfield T, Ogbogu U, Nelson E, Einsiedel E, Knoppers B, McDonald M, Brunger F, Downey R, Fernando K, Galipeau J, Geransar R, Grenier G, Hyun I, Isasi R, Kardel M, et al. Stem cell research ethics: consensus statement on emerging issues Journal of Obstetrics and Gynaecology Canada : Jogc = Journal D'ObstéTrique Et GynéCologie Du Canada : Jogc. 29: 843-848. PMID 17915069 DOI: 10.1016/S1701-2163(16)32632-9 |
0.743 |
|
| 2007 |
Caulfield T, Ogbogu U, Isasi RM. Informed consent in embryonic stem cell research: Are we following basic principles? Canadian Medical Association Journal. 176: 1722-1725. PMID 17548387 DOI: 10.1503/Cmaj.061675 |
0.445 |
|
| 2007 |
Caulfield T, Bubela T. Why a Criminal Ban? Analyzing the Arguments Against Somatic Cell Nuclear Transfer in the Canadian Parliamentary Debate American Journal of Bioethics. 7: 51-61. PMID 17366198 DOI: 10.1080/15265160601109655 |
0.38 |
|
| 2007 |
Caulfield T. Human cloning a decade after Dolly Canadian Medical Association Journal. 176: 613-613. PMID 17325318 DOI: 10.1503/Cmaj.070182 |
0.308 |
|
| 2007 |
Caulfield T, Brown R, Meslin EM. Challenging a Well Established Consent Norm?: One Time Consent for Biobank Research Journal of International Biotechnology Law. 4: 69-74. DOI: 10.1515/Jibl.2007.010 |
0.375 |
|
| 2007 |
Caulfield T. Biobanks and Blanket Consent: The Proper Place of the Public Good and Public Perception Rationales King's Law Journal. 18: 209-226. DOI: 10.1080/09615768.2007.11427674 |
0.442 |
|
| 2006 |
Caulfield T, Einsiedel E, Merz JF, Nicol D. Trust, patents and public perceptions: the governance of controversial biotechnology research. Nature Biotechnology. 24: 1352-4. PMID 17093477 DOI: 10.1038/Nbt1106-1352 |
0.423 |
|
| 2006 |
Caulfield T, Cook-Deegan RM, Kieff FS, Walsh JP. Evidence and anecdotes: an analysis of human gene patenting controversies. Nature Biotechnology. 24: 1091-4. PMID 16964215 DOI: 10.1038/Nbt0906-1091 |
0.312 |
|
| 2006 |
Caulfield T, Tigerstrom Bv. Gene patents, health care policy and licensing schemes. Trends in Biotechnology. 24: 251-254. PMID 16621074 DOI: 10.1016/J.Tibtech.2006.03.007 |
0.368 |
|
| 2006 |
Billingsley B, Caulfield T. The regulation of science and the Charter of Rights: would a ban on non-reproductive human cloning unjustifiably violate freedom of expression? Queen's Law Journal. 29: 647-79. PMID 16514767 |
0.302 |
|
| 2006 |
Caulfield T, Brownsword R. Human dignity: a guide to policy making in the biotechnology era? Nature Reviews Genetics. 7: 72-76. PMID 16344853 DOI: 10.1038/Nrg1744 |
0.353 |
|
| 2006 |
Koper M, Bubela T, Caulfield T, Boon H. Media portrayal of conflicts of interest in herbal remedy clinical trials. Health Law Review. 15: 9-11. DOI: 10.7939/R3M00F |
0.36 |
|
| 2006 |
DeBow S, Bubela T, Caulfield T. Stem cells, politics and the progress paradigm. Health Law Review. 15: 50. DOI: 10.7939/R3B28P |
0.48 |
|
| 2006 |
Bubela T, Caulfield T, Boon H. Trends in Evidence-Based Medicine for Herbal Remedies and Media Coverage Health Law Review. 15: 3. DOI: 10.7939/R34003 |
0.343 |
|
| 2006 |
Caulfield T. Stem Cell Patents and Social Controversy: A Speculative View from Canada Medical Law International. 7: 219-232. DOI: 10.1177/096853320600700304 |
0.385 |
|
| 2005 |
Caulfield T, Chapman A. Human dignity as a criterion for science policy. Plos Medicine. 2. PMID 16042507 DOI: 10.1371/Journal.Pmed.0020244 |
0.327 |
|
| 2005 |
Caulfield T, DeBow S. A systematic review of how homeopathy is represented in conventional and CAM peer reviewed journals. Bmc Complementary and Alternative Medicine. 5: 12. PMID 15955254 DOI: 10.1186/1472-6882-5-12 |
0.364 |
|
| 2005 |
Ries NM, Caulfield T. Legal foundations for a national public health agency in Canada. Canadian Journal of Public Health-Revue Canadienne De Sante Publique. 96: 281-283. DOI: 10.1007/Bf03405164 |
0.343 |
|
| 2004 |
Caulfield T. The commercialisation of medical and scientific reporting. Plos Medicine. 1. PMID 15630461 DOI: 10.1371/Journal.Pmed.0010038 |
0.339 |
|
| 2004 |
Kleinman S, Caulfield T, Chan P, Davenport R, McFarland J, McPhedran S, Meade M, Morrison D, Pinsent T, Robillard P, Slinger P. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion. 44: 1774-89. PMID 15584994 DOI: 10.1111/J.0041-1132.2004.04347.X |
0.339 |
|
| 2004 |
Caulfield T, Lemmens T, Kinsella D, McDonald M. Research ethics and the role of the professional bodies: a view from Canada. The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics. 32: 365-8. PMID 15301201 DOI: 10.1111/J.1748-720X.2004.Tb00483.X |
0.563 |
|
| 2004 |
Caulfield T, Knowles L, Meslin EM. Law and policy in the era of reproductive genetics Journal of Medical Ethics. 30: 414-417. PMID 15289541 DOI: 10.1136/Jme.2002.001370 |
0.413 |
|
| 2004 |
Caulfield T. Scientific freedom and research cloning: can a ban be justified? The Lancet. 364: 124-126. PMID 15246714 DOI: 10.1016/S0140-6736(04)16653-1 |
0.385 |
|
| 2004 |
Caulfield T. Biotechnology and the popular press: hype and the selling of science. Trends in Biotechnology. 22: 337-339. PMID 15245905 DOI: 10.1016/J.Tibtech.2004.03.014 |
0.4 |
|
| 2004 |
Bubela TM, Caulfield TA. Do the print media "hype" genetic research? A comparison of newspaper stories and peer-reviewed research papers. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 170: 1399-407. PMID 15111473 DOI: 10.1503/Cmaj.1030762 |
0.408 |
|
| 2004 |
Caulfield T, Sheremeta L. Biotechnology Patents and Embryonic Stem Cell Research: Emerging Issues (Part I) Journal of International Biotechnology Law. 1: 98-104. DOI: 10.1515/Jibl.2004.1.3.98 |
0.41 |
|
| 2003 |
Caulfield T. Human cloning laws, human dignity and the poverty of the policy making dialogue. Bmc Medical Ethics. 4: 3. PMID 12887735 DOI: 10.1186/1472-6939-4-3 |
0.335 |
|
| 2003 |
Caulfield TA. From human genes to stem cells: new challenges for patent law? Trends in Biotechnology. 21: 101-3. PMID 12628363 DOI: 10.1016/S0167-7799(03)00006-4 |
0.426 |
|
| 2003 |
Caulfield T, Knoppers B, Gold E, Sheremeta L, Bridge P. Genetic technologies, health care policy and the patent bargain. Clinical Genetics. 63: 15-18. PMID 12519367 DOI: 10.1034/J.1399-0004.2003.630103.X |
0.354 |
|
| 2003 |
Caulfield T, Upshur RE, Daar AS. DNA databanks and consent: A suggested policy option involving an authorization model Bmc Medical Ethics. 4: 1-4. PMID 12513704 DOI: 10.1186/1472-6939-4-1 |
0.377 |
|
| 2002 |
Caulfield T. Ethics watch. Public perceptions and regulatory policy. Nature Reviews Genetics. 3: 902-902. PMID 12494928 DOI: 10.1038/Nrg957 |
0.355 |
|
| 2002 |
Gold ER, Caulfield TA. The moral tollbooth: a method that makes use of the patent system to address ethical concerns in biotechnology. Lancet (London, England). 359: 2268-70. PMID 12103305 DOI: 10.1016/S0140-6736(02)09298-X |
0.407 |
|
| 2002 |
Caulfield T, Griener G. Conflicts of interest in clinical research: addressing the issue of physician remuneration. The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics. 30: 305-8. PMID 12066609 DOI: 10.1111/J.1748-720X.2002.Tb00398.X |
0.375 |
|
| 2001 |
Caulfield TA, Robertson GB. Xenotransplantation: Consent, Public Health and Charter Issues Medical Law International. 5: 81-99. PMID 14696619 DOI: 10.1177/096853320100500201 |
0.381 |
|
| 2001 |
Caulfield T. Liability in the Genetic Era: Wrongful Birth and Wrongful Life Lawsuits Journal Sogc. 23: 143-147. DOI: 10.1016/S0849-5831(16)30157-4 |
0.328 |
|
| 2000 |
Caulfield T, Gold ER, Cho MK. Patenting human genetic material: Refocusing the debate Nature Reviews Genetics. 1: 227-231. PMID 11252752 DOI: 10.1038/35042087 |
0.34 |
|
| 1999 |
Caulfield T, Hirtle M. Regulating the genetic revolution. Molecular Medicine Today. 5: 198-200. PMID 10322311 DOI: 10.1016/S1357-4310(99)01467-7 |
0.368 |
|
| 1999 |
Florencio PS, Caulfield T. Xenotransplantation and public health: Identifying the legal issues Canadian Journal of Public Health-Revue Canadienne De Sante Publique. 90: 282-284. DOI: 10.17269/Cjph.90.1184 |
0.361 |
|
| 1998 |
Caulfield T. Reply to Ian Dunham Molecular Medicine Today. 4: 336. DOI: 10.1016/S1357-4310(98)01306-9 |
0.308 |
|
| 1998 |
Caulfield T. The Commercialization of Human Genetics: A Discussion of Issues Relevant to the Canadian Consumer Journal of Consumer Policy. 21: 125-168. DOI: 10.1007/978-1-4615-5311-3_5 |
0.355 |
|
| 1969 |
Caulfield T. Clones, controversy, and criminal law: a comment on the proposal for legislation governing assisted human reproduction. Alberta Law Review. 39: 335. DOI: 10.29173/Alr1409 |
0.333 |
|
| 1969 |
Caulfield T. Gene Patents, Human Clones, and Biotechnology Policy: The Challenges Created by Globalization Alberta Law Review. 41: 713-713. DOI: 10.29173/Alr1320 |
0.363 |
|
| Show low-probability matches. |
